HTLV-related Adult T Cell Leukemia/Lymphoma: Research in the United States
Chapter 1In this video, Adrienne Phillips, MD, MPH, a board certified hematologist and medical oncologist at Weill Cornell Medicine/New York-Presbyterian Hospital, discusses her research into human T cell lymphotropic virus (HTLV)-related adult T cell leukemia/lymphoma, including a study in which she and colleagues were able to identify 4 prognostic features in this setting.
Mogamulizumab for HTLV-related Adult T Cell Leukemia/Lymphoma
In this video, Adrienne Phillips, MD, MPH, a board certified hematologist and medical oncologist at Weill Cornell Medicine/New York-Presbyterian Hospital, discusses an important study on the efficacy of mogamulizumab in patients with human T cell lymphotropic virus (HTLV)-related adult T cell leukemia/lymphoma.
Tailoring Treatments in Adult T Cell Leukemia/Lymphoma
In this video, Adrienne Phillips, MD, MPH, a board certified hematologist and medical oncologist at Weill Cornell Medicine/New York-Presbyterian Hospital, discusses some ongoing research into precision medicine for patients with non-Hodgkin lymphoma.
Specializing Care in Adult T Cell Leukemia/Lymphoma
In this video, Adrienne Phillips, MD, MPH, a board certified hematologist and medical oncologist at Weill Cornell Medicine/New York-Presbyterian Hospital, discusses her and experience with treating adult T cell leukemia/lymphoma, as well as a number of ongoing trials in the area.
